[{"NetIncomeLoss_1_Q2_USD":-43880000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":774000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":105000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":-5390000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":0.0,"MarketableSecuritiesCurrent_0_Q2_USD":69495000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":46345585.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":46420046.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":15478000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":0.0,"AccruedLiabilitiesCurrent_0_Q2_USD":51756000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":1801000.0,"InterestPaidNet_2_Q2_USD":4818000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":108000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":21493000.0,"CostOfGoodsAndServicesSoldAmortization_2_Q2_USD":399000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q2_USD":200000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":95000.0,"AssetsCurrent_0_Q2_USD":159865000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":39907000.0,"Liabilities_0_Q2_USD":284516000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":74664000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":4607000.0,"OtherAssetsNoncurrent_0_Q2_USD":514000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q2_USD":4070000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":83890000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":44881000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":95000.0,"PrepaidExpenseCurrent_0_Q2_USD":7921000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-1274000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-59000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-68000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-132000.0,"CommonStockValue_0_Q2_USD":5000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_security":4.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":992000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":945000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":10929000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":95000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":125700000.0,"OtherAssetsCurrent_0_Q2_USD":1838000.0,"IncreaseDecreaseInInventories_2_Q2_USD":583000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-81429000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-43106000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":5688000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":56239000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":38231000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":61400000.0,"CommonStockSharesIssued_0_Q2_shares":46448491.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-13647000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":9939000.0,"CommonStockSharesOutstanding_0_Q2_shares":46448491.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":203000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":13299000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7840000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-46069000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":3456000.0,"LiabilitiesCurrent_0_Q2_USD":65654000.0,"AccountsPayableCurrent_0_Q2_USD":11718000.0,"InterestExpense_2_Q2_USD":13678000.0,"InterestExpense_1_Q2_USD":6922000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":56806000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":990000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":56239000.0,"AdditionalPaidInCapital_0_Q2_USD":1208616000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":990000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":6184000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":15478000.0,"OperatingLeasePayments_2_Q2_USD":1175000.0,"ReceivablesNetCurrent_0_Q2_USD":17899000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1747000.0,"NetIncomeLoss_2_Q2_USD":-81534000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1318148000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":8725000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":69387000.0,"RestrictedCashEquivalentsCurrent_0_Q2_USD":567000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":649000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":69495000.0,"Assets_0_Q2_USD":175097000.0,"SecuredDebt_0_Q2_USD":9940000.0,"ShareBasedCompensation_2_Q2_USD":13299000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":6787000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-4210000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":98037000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":50113000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_2_Q2_USD":7931000.0,"OperatingIncomeLoss_2_Q2_USD":-68847000.0,"InventoryNet_0_Q2_USD":5906000.0,"InvestmentIncomeInterest_2_Q2_USD":1050000.0,"InvestmentIncomeInterest_1_Q2_USD":379000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":175097000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2180000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":1110000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.95,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.76,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":-109419000.0,"OperatingIncomeLoss_1_Q2_USD":-37269000.0,"ConvertibleDebt_0_Q2_USD":204315000.0,"Ticker":"RDUS","CIK":"1428522","name":"RADIUS HEALTH, INC.","OfficialName":"Radius Health Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"368163999.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]